Cell Marque Antibodies Naval Medical Center San Diego
Closed Special Notice Posted
- Solicitation number
- HT941024N0090
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- San Diego, California 92134, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency Contracting Activity (DHACA), Western Healthcare Operations Contracting Division (WHOCD), has issued a Notice of Intent to award a sole source firm fixed-price supply contract for Cell Marque Antibodies to be used in the Histology Division at the Naval Medical Center San Diego (NMCSD). The objective is to procure various Cell Marque antibodies for immunohistochemical testing using Ventana BenchMark autostainers.
The notice states that Cell Marque Corporation is the only source capable of meeting the government's requirements for the requested antibodies. Interested contractors must submit capability statements by July 11, 2024, demonstrating their ability to provide the required items. The government will review the submissions to determine whether to proceed with a sole source purchase or conduct a competitive procurement. The delivery date for the antibodies is September 30, 2024, with delivery to the Laboratory Department at NMCSD. The applicable NAICS code is 325413 - In-Vitro Diagnostic Substance Manufacturing, and the PSC code is 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets.
Notice text
Notice of Intent to Sole Source HT941024N0090
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Western Healthcare Operations Contracting Division (WHOCD), intends to award a firm fixed price supply purchase for Cell Marque Antibodies in the Histology Division at the Laboratory Department in Naval Medical Center San Diego (NMCSD), in accordance with the Federal Acquisition Regulation (FAR) 13.901(a) Sole Source acquisitions and FAR 13.106-1(b)(1)(i), only one source being available to meet the Government’s needs, to:
Cell Marque Corporation
6600 Sierra College BLVD
Rocklin, California
95677-4306, United States
The North American Industry Classification System (NAICS) code for this requirement is 325413 In-Vitro Diagnostic Substance Manufacturing 1250 (# of employees). The Product Service Code (PSC) is 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets.
The objective of this sole source award is to procure antibodies for Immunohistochemical testing using the Ventana BenchMark autostainers. The requested antibodies have been previously sourced for Cell Marque and have all been validated. Cell Marque antibodies are designed to be used in Ventana BenchMark stainers. Required items listed as below:
Catalog # Description
383R-10 SOX-10 (EP268), 25ml, predilute
384R-18 SATB2 (EP281), 7ml, predilute
343M-98 TTF-1 (8G7G3/1), 7ml, predilute
393A-18 Adipophilin (Polyclonal), 7ml, predilute
236A-18 CEA (Polyclonal), 7ml, predilute
313M-10 Cytokeratin Cocktail (AE1 & AE3), 25ml
307M-98 Cytokeratin 7 (OV-TL 12/30), 7ml, predilute
504R-10 P504s (13H4), 25ml, predilute
117R-10-ASR CD117. C-KIT (YR145), 25ml, predilute
115M-18 CD15 (MMA), 7ml, predilut
130M-98 CD30 (BER-H2), 7ml, predilute
108M-98 CD8 (C8/144B), 7ml, predilute
199R-18 CD99 (EPR3097Y), 7ml, predilute
254M-18 FLI-1 (MRQ-1), 7ml, predilute
338A-78 TDT, 7ml, predilute
360R-18 Hemoglobin A (EPR3608), 7ml, predilute
213M-18-ASR Cytomegalovirus (DDG9/CCH2), 7ml
397A-18-ASR Treponema pallidum (Polyclonal), 7ml
224M-18 BETA-CATENIN (14), 7ml, predilute
Deliver Schedule: 09/30/2024
Deliver location:
Laboratory Department
Naval Medical Center San Diego (NMCSD)
34800 Bob Wilson Dr, San Diego, CA 92134
Cell Marque Corporation is the only source that can meet the Government’s minimum requirements to provide the requested antibodies mentioned above at Naval Medical Center San Diego.
This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the above requirement for Naval Medical Center San Diego. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.
If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Zhao Li at zhao.k.li.civ@health.mil.
The closing date for challenges is no later than 0900 Pacific Daylight Time, Monday, 11 July 2024.
NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.
Files
| File | Type | Posted |
|---|---|---|
| HT941024N0090 Notice of Intent to Sole Source_CellMarque Antibodies.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) | National Institute of Allergy and Infectious Diseases | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity